Access to Affordable Medicines? The Case of CAFTA in Guatemala
Washington DC readers of the Social Medicine Portal may be interested in attending the release of a report by the Center for Policy Analysis on Trade and Health (CPATH) on the effect of CAFTA-DR (the Central America – Dominican Republic US Free Trade Agreement) on access to medications. This is a topic we have covered previously on the Portal (see: Trade & Health at 2008 American Public Health Association Meeting).
The release will take place on Wednesday, August 26 from noon to 2PM at the University of California DC Washington Center, 1608 Rhode Island Ave. NW. A light lunch will be served. Speaking at the release will be Ellen R. Shaffer, PhD MPH and Joe Brenner, MA, co-Directors of the Center for Policy Analysis on Trade and Health.
Please RSVP, acceptances only, to Joseph R. McGhee at the IGCC Washington office: Phone (202) 974-6295; Fax (202) 974-6299; email: joseph.mcghee@ucdc.edu . For more on IGCC, see http://www-igcc.ucsd.edu.
We will post links and commentary about the report when it is released on Wednesday.
posted by Matt Anderson, MD
CPATH’s article in “Health Affairs’” on the effect of CAFTA on access to medicines is available online at the links below for the next 2 weeks. (Aug. 25 – Sept. 6, 2009). To obtain a copy of the article after 9/6/2009, please write to: ershaffer@gmail.com
http://www.cpath.org/id40.html
http://content.healthaffairs.org/cgi/content/full/hlthaff.28.5.w957/DC1